查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2048320

藥品溯源市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、最終用戶、地區和競爭格局分類，2021-2031年

Pharmaceutical Traceability Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Barcode, GPS, RFID), By End-User (Hospitals, Pharmacies, Ambulatory Care Centers), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球藥品追溯市場預計將從 2025 年的 221.3 億美元大幅成長至 2031 年的 629.1 億美元，複合年成長率達 19.02%。

該市場包含一個由軟體、硬體和標準組成的整合網路，旨在追蹤和管理整個供應鏈中的處方藥，從而確保從製造商到配藥點的產品真實性。

市場概覽
預測期 2027-2031
市場規模：2025年 221.3億美元
市場規模：2031年 629.1億美元
複合年成長率：2026-2031年 19.02%
成長最快的細分市場 條碼
最大的市場 北美洲

市場促進因素

這項擴張主要受全球日益嚴格的序列化和可追溯性要求所驅動，包括美國《藥品供應鏈安全法案》和歐盟《反仿冒藥品指令》等法規。這些監管壓力迫使製造商和供應鏈相關人員實施可互通的合規平台，以保護其供應鏈免受假冒產品的侵害，行業向數位化合規解決方案的快速轉型便印證了這一點。同時，隨著假藥、藥品竊盜和藥品召回事件的增加，迫切需要先進的視覺化解決方案，不僅用於真偽檢驗，還用於有效管理安全事件和全面提升病患安全。

市場挑戰

儘管取得了這些進展，但建立跨不同相關人員系統的完全互通性的高成本和技術複雜性仍然是市場進一步擴張的主要障礙。中小企業往往缺乏資金升級基礎設施，難以維持無縫合規所需的嚴格資料完整性。正如70%的物流營運每週都會遇到條碼讀取問題所顯示的那樣，這種營運摩擦需要昂貴的人工干預，從而降低了可追溯性技術的投資報酬率。因此，實現穩健市場成長所需的普遍可視性的能力受到阻礙。

市場趨勢

然而，在關鍵技術趨勢的驅動下，市場正經歷一場變革性的轉變。人工智慧 (AI) 在預測性供應鏈分析中的應用，正顯著改變著營運模式，使其從被動監控轉向主動應對，使相關人員能夠透過機器學習演算法預測中斷，並利用序列化資料進行策略性風險管理，從而超越單純的合規要求。同時，市場正在加速採用 GS1 數位連結和2D條碼。這些先進的資料載體能夠在一次掃描中嵌入更詳細、更精細的信息，例如有效期和批號，從而促進超越基本合規要求的資訊交流，並簡化複雜的物流流程，最終有助於提高供應鏈的透明度和實現互操作性標準化。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球藥品追溯市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（條碼、GPS、RFID）
    • 依最終用戶（醫院、藥局、門診）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美藥品可追溯性市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲藥品可追溯性市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區藥品追溯市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲藥品可追溯性市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美藥品可追溯性市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球藥品追溯市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Optel Group
  • The Healthcare Distribution Alliance（HDA）
  • Bureau Veritas SA
  • Logista Pharma SA
  • Rfxcel Corp
  • Movilitas Consulting AG
  • TraceLink Inc
  • Avery Dennison Corp
  • Cognex Corp

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 17536

The Global Pharmaceutical Traceability Market is projected for substantial growth, expanding from USD 22.13 billion in 2025 to USD 62.91 billion by 2031, at a 19.02% compound annual growth rate. This market encompasses an integrated network of software, hardware, and standards developed to track and trace prescription medications across the entire supply chain, thereby ensuring product authenticity from the manufacturer to the point of dispensing.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 22.13 Billion
Market Size 2031USD 62.91 Billion
CAGR 2026-203119.02%
Fastest Growing SegmentBarcode
Largest MarketNorth America

Market Driver

This expansion is primarily propelled by the enforcement of stringent global serialization and traceability mandates, including regulations like the Drug Supply Chain Security Act in the US and the Falsified Medicines Directive in Europe. These regulatory pressures compel manufacturers and supply chain stakeholders to adopt interoperable compliance platforms to secure the supply chain against illegitimate products, as evidenced by rapid industry shifts toward digital compliance solutions. Concurrently, the rising prevalence of counterfeit drugs and pharmaceutical theft, along with increasing pharmaceutical recall events, critically necessitates advanced visibility solutions not only for verifying authenticity but also for efficiently managing safety events and improving overall patient safety.

Market Challenge

Despite this progress, a significant impediment to broader market expansion remains the high cost and technical complexity associated with establishing full interoperability across diverse stakeholder systems. Smaller and mid-sized entities frequently lack the financial resources to upgrade infrastructure, leading to difficulties in maintaining the rigorous data integrity required for seamless compliance. This operational friction, highlighted by 70 percent of logistics operations experiencing weekly barcode readability issues, necessitates expensive manual interventions and diminishes the return on investment for traceability technologies, thereby hindering the market's ability to achieve universal visibility required for robust growth.

Market Trends

Nevertheless, the market is undergoing a transformative shift driven by key technological trends. The adoption of artificial intelligence for predictive supply chain analytics is notably transforming operations from reactive monitoring to proactive resilience, enabling stakeholders to anticipate disruptions through machine learning algorithms and leverage serialization data for strategic risk management beyond solely regulatory adherence. Simultaneously, the market is witnessing increased momentum in the adoption of GS1 Digital Link and 2D barcodes. These advanced data carriers embed richer, granular details like expiration dates and batch numbers within a single scan, facilitating enhanced information exchange and streamlining complex logistics beyond fundamental compliance mandates, ultimately contributing to improved visibility and interoperable standardization.

Key Market Players

  • Optel Group
  • The Healthcare Distribution Alliance (HDA)
  • Bureau Veritas SA
  • Logista Pharma SA
  • Rfxcel Corp
  • Movilitas Consulting AG
  • TraceLink Inc
  • Avery Dennison Corp
  • Cognex Corp

Report Scope

In this report, the Global Pharmaceutical Traceability Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Traceability Market, By Type

  • Barcode
  • GPS
  • RFID

Pharmaceutical Traceability Market, By End-User

  • Hospitals
  • Pharmacies
  • Ambulatory Care Centers

Pharmaceutical Traceability Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Traceability Market.

Available Customizations:

Global Pharmaceutical Traceability Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Traceability Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Barcode, GPS, RFID)
    • 5.2.2. By End-User (Hospitals, Pharmacies, Ambulatory Care Centers)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Pharmaceutical Traceability Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End-User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pharmaceutical Traceability Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End-User
    • 6.3.2. Canada Pharmaceutical Traceability Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End-User
    • 6.3.3. Mexico Pharmaceutical Traceability Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End-User

7. Europe Pharmaceutical Traceability Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End-User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pharmaceutical Traceability Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End-User
    • 7.3.2. France Pharmaceutical Traceability Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End-User
    • 7.3.3. United Kingdom Pharmaceutical Traceability Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End-User
    • 7.3.4. Italy Pharmaceutical Traceability Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End-User
    • 7.3.5. Spain Pharmaceutical Traceability Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End-User

8. Asia Pacific Pharmaceutical Traceability Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End-User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pharmaceutical Traceability Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End-User
    • 8.3.2. India Pharmaceutical Traceability Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End-User
    • 8.3.3. Japan Pharmaceutical Traceability Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End-User
    • 8.3.4. South Korea Pharmaceutical Traceability Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End-User
    • 8.3.5. Australia Pharmaceutical Traceability Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End-User

9. Middle East & Africa Pharmaceutical Traceability Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End-User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pharmaceutical Traceability Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End-User
    • 9.3.2. UAE Pharmaceutical Traceability Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End-User
    • 9.3.3. South Africa Pharmaceutical Traceability Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End-User

10. South America Pharmaceutical Traceability Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End-User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pharmaceutical Traceability Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End-User
    • 10.3.2. Colombia Pharmaceutical Traceability Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End-User
    • 10.3.3. Argentina Pharmaceutical Traceability Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pharmaceutical Traceability Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Optel Group
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. The Healthcare Distribution Alliance (HDA)
  • 15.3. Bureau Veritas SA
  • 15.4. Logista Pharma SA
  • 15.5. Rfxcel Corp
  • 15.6. Movilitas Consulting AG
  • 15.7. TraceLink Inc
  • 15.8. Avery Dennison Corp
  • 15.9. Cognex Corp

16. Strategic Recommendations

17. About Us & Disclaimer